Scientists have discovered a new metabolic process in the body that can switch off inflammation. They have discovered that ‘itaconate’ – a molecule derived from glucose – acts as a powerful off-switch for macrophages, which are the cells in the immune system that lie at the heart of many inflammatory diseases including arthritis, inflammatory bowel disease and heart disease.
The scientists, working in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute at Trinity College Dublin, hope their discovery will have relevance for inflammatory and infectious diseases – and that their findings may also help to develop much-needed new drugs to treat people living with these conditions.
Professor of Biochemistry at Trinity, Luke O’Neill, was, along with Dr Mike Murphy of the University of Cambridge, the joint leader of the work just published in leading international journal Nature. The discoveries were made using both human cells and mice as a model organism.
Professor O’Neill said: “My lab has been exploring metabolic changes in macrophages for the past six years and we’ve come across what we think is the most important finding yet.”
“It is well known that macrophages cause inflammation, but we have just found that they can be coaxed to make a biochemical called itaconate. This functions as an important brake, or off-switch, on the macrophage, cooling the heat of inflammation in a process never before described.”
Dr Evanna Mills, who, with Dylan Ryan was joint first author of the work, said: “The macrophage takes the nutrient glucose, whose day job it is to provide energy, and surprisingly turns it into itaconate. This then blocks production of inflammatory factors, and also protects mice from the lethal inflammation that can occur during infection.”
Dylan Ryan added: “We’ve found that itaconate can directly modify a whole host of proteins important for inflammation in a chemical reaction never before described, and that this reaction is important for the anti-inflammatory effects of itaconate.”
The discovery is very much on the frontier of inflammation research and Professor O’Neill and his collaborators are now exploring its relevance to the onset and development of inflammatory and infectious diseases. They are also keen to explore whether the findings can be exploited in the effort to develop new anti-inflammatory medicines.
The work was a collaboration with Harvard Medical School, the University of Cambridge, the University of Oxford, Johns Hopkins University, the University of Dundee, and GlaxoSmithKline, where both Professor O’Neill and Dr Mills spent time on sabbatical.
Professor O’Neill said: “This discovery and the new research pathways it has opened up will keep us busy for some time but we are hopeful that it will one day make a difference to patients with diseases that remain difficult to treat.”
The Latest on: Inflammation
via Google News
The Latest on: Inflammation
- Sympathetic nervous system controls resolution of inflammation via regulation of repulsive guidance molecule A on February 7, 2019 at 2:10 am
The bidirectional communication between the immune and nervous system is important in regulating immune responses. Here we show that the adrenergic nerves of sympathetic nervous system orchestrate inf... […]
- Modulation of the sigma-1 receptor–IRE1 pathway is beneficial in preclinical models of inflammation and sepsis on February 6, 2019 at 11:40 am
1 Center for Brain Immunology and Glia, Department of Neuroscience, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA. 2 Graduate Program in Pharmacological Sciences, School o... […]
- Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis on February 6, 2019 at 11:05 am
Department of Biological Sciences, Virginia Tech, Blacksburg, VA 24061, USA. Nonresolving inflammation perpetuated by innate leukocytes is involved in the pathogenesis of unstable atherosclerosis. How... […]
- L1 drives IFN in senescent cells and promotes age-associated inflammation on February 6, 2019 at 10:11 am
Retrotransposable elements are deleterious at many levels, and the failure of host surveillance systems for these elements can thus have negative consequences. However, the contribution of retrotransp... […]
- Health Authorities Warn Not to Take Chronic Inflammation for Granted on February 6, 2019 at 1:09 am
According to researchers, chronic inflammation triggers the body to stay on high alert all of the time. This leads to lasting damage to the brain, heart, and some other organs. Studies have found ... […]
- Lyme Disease Brain Inflammation on February 5, 2019 at 4:12 pm
1 in 10 people who have been successfully treated with antibiotics for Lyme disease will develop chronic and sometimes debilitating poorly understood symptoms of brain fog and fatigue that can last fo... […]
- New scan technique reveals brain inflammation associated with post-treatment Lyme disease syndrome on February 5, 2019 at 6:31 am
More than 1 in 10 people successfully treated with antibiotics for Lyme disease go on to develop chronic, sometimes debilitating, and poorly understood symptoms of fatigue and brain fog that may ... […]
- EPA-Registered Herbicide Found to Trigger Inflammation Linked to Onset of Multiple Sclerosis on February 4, 2019 at 8:04 pm
(Beyond Pesticides, February 5, 2019) Linuron, an herbicide registered for use by the U.S. Environmental Protection Agency (EPA), yet recently banned in Europe due to health concerns, appears to trigg... […]
- 7 herbs for inflammation to start sprinkling into your diet on February 4, 2019 at 11:06 am
It seems like anytime you read about some sort of health issues, inflammation (a defensive mechanism your immune system activates automatically to deal with what it deems to be “foreign substances” in ... […]
via Bing News